Compounds > fluorouracil

fluorouracil and metallothionein

fluorouracil has been researched along with metallothionein in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	3 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Ishimura, H	1
Imura, N; Miura, N; Naganuma, A; Okazaki, Y; Satoh, M	1
Allegra, C; Aloia, T; D'Amico, TA; Harpole, DH; Herndon, JE; Linoila, I; Moore, MB; Parr, A; Sporn, T	1
Dhar, DK; Hishikawa, Y; Kimoto, T; Kohno, H; Koji, T; Kubota, H; Nagasue, N; Tachibana, M; Ueda, S	1
Doki, Y; Kishi, K; Miyata, H; Monden, M; Yano, M; Yasuda, T	1
Chang, Z; Chen, L; Gao, Y; Li, K; Liang, W; Lu, Y; Sun, S; Wang, C; Xu, X; Zhang, H	1

Other Studies

6 other study(ies) available for fluorouracil and metallothionein

Article	Year
[Chemosensitivity test on hepatocellular carcinoma (HCC) and drug resistance]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1996, Volume: 71, Issue:6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cisplatin; Cytochrome P-450 Enzyme System; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Glutathione Transferase; Humans; Liver Neoplasms; Metallothionein; Mitomycins; Tumor Cells, Cultured	1996
Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice. Biochemical and biophysical research communications, 1998, Apr-28, Volume: 245, Issue:3 Topics: Animals; Antineoplastic Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Metallothionein; Mice; Mitomycin; Neoplasm Transplantation; Tumor Cells, Cultured; Vinblastine	1998
The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:3 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Fluorouracil; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Metallothionein; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Thymidylate Synthase; Time Factors; Treatment Outcome	2001
Expression of metallothionein in colorectal cancers and synchronous liver metastases. Oncology, 2001, Volume: 61, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Life Tables; Liver Neoplasms; Male; Metallothionein; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Prognosis; Survival Analysis	2001
Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer. The British journal of surgery, 2002, Volume: 89, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; cdc25 Phosphatases; Cell Cycle Proteins; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Genes, p53; Humans; Immunohistochemistry; Infusions, Intravenous; Male; Metallothionein; Middle Aged; Survival Analysis; Treatment Outcome	2002
MT1M regulates gastric cancer progression and stemness by modulating the Hedgehog pathway protein GLI1. Biochemical and biophysical research communications, 2023, 08-30, Volume: 670 Topics: Cell Line, Tumor; Cell Proliferation; Fluorouracil; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Metallothionein; Stomach Neoplasms; Zinc Finger Protein GLI1	2023